<DOC>
	<DOCNO>NCT01746550</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness MD-12-001 stent treatment superficial femoral artery proximal popliteal artery blockages Japanese patient .</brief_summary>
	<brief_title>A Safety Effectiveness Study MD-12-001 Stent Treatment Superficial Femoral Artery Popliteal Artery Blockages Japanese Patients</brief_title>
	<detailed_description />
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Key Rutherford Category 24 ( mild intermittent claudication ( pain walk ) ischemic pain ( pain due decrease blood flow ) rest ) . The target lesion ( ) evidence narrow blockage stented . The total length lesion series lesion estimate less equal 150 mm . The target vessel reference diameter great equal 4.0 mm less equal 6.5 mm Key The subject know reaction ( include allergic reaction ) sensitivity blood thin medication , study device material ( nickel , titanium tantalum ) The subject know sensitivity medical imaging substance ( contract medium ) pretreated medication ( steroid or/and antihistamine ) The subject history bleeding disorder ( diatheses coagulopathy ) . The subject kidney failure dialysis treatment . The subject insufficient liver function , swell vein ( ) cause blood clot ( thrombophlebitis ) , uremia , systemic lupus , deep vein blood clot . Subject Acute Limb Ischemia ( sudden loss blood flow limb ) . Subject history bypass surgery study vessel . Subject history heart attack stroke within 6 month study procedure . The subject receive immunosuppressive therapy ( medication low body 's normal immune response ) . The subject diagnose severe infection ( septicemia ) . Principal investigator determine subject 's condition would prevent subject undergo study procedure support vascular bypass graft . The subject stent previously implant target vessel . Subject disease legs limbs meet inclusion criterion plan treat limb within 30 day . Pregnant , possibly pregnant and/or nurse female subject exclude , female subject willing baby trial . The subject participate investigational drug another investigational device study . Subject large amount blood clot next study lesion .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>